-
1
-
-
36049037819
-
Bevacizumab plus irinotecan in recurrent glioblastoma multiforme
-
DOI 10.1200/JCO.2007.12.2440
-
JJ Vredenburgh A Desjardins JE Herndon J Marcello DA Reardon JA Quinn JN Rich S Sathornsumetee S Gururangan J Sampson M Wagner L Bailey DD Bigner AH Friedman HS Friedman 2007 Bevacizumab plus irinotecan in recurrent glioblastoma multiforme J Clin Oncol 25 4722 4729 10.1200/JCO.2007.12.2440 1:CAS:528:DC%2BD2sXhtlCgsLjF 17947719 (Pubitemid 350086473)
-
(2007)
Journal of Clinical Oncology
, vol.25
, Issue.30
, pp. 4722-4729
-
-
Vredenburgh, J.J.1
Desjardins, A.2
Herndon II, J.E.3
Marcello, J.4
Reardon, D.A.5
Quinn, J.A.6
Rich, J.N.7
Sathornsumetee, S.8
Gururangan, S.9
Sampson, J.10
Wagner, M.11
Bailey, L.12
Bigner, D.D.13
Friedman, A.H.14
Friedman, H.S.15
-
2
-
-
41649112610
-
Bevacizumab for recurrent malignant gliomas: Efficacy, toxicity, and patterns of recurrence
-
10.1212/01.wnl.0000304121.57857.38 1:CAS:528:DC%2BD1cXitlyqs7o%3D 18316689
-
AD Norden GS Young K Setayesh A Muzikansky R Klufas GL Ross AS Ciampa LG Ebbeling B Levy J Drappatz S Kesari PY Wen 2008 Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence Neurology 70 779 787 10.1212/01.wnl.0000304121.57857.38 1:CAS:528:DC%2BD1cXitlyqs7o%3D 18316689
-
(2008)
Neurology
, vol.70
, pp. 779-787
-
-
Norden, A.D.1
Young, G.S.2
Setayesh, K.3
Muzikansky, A.4
Klufas, R.5
Ross, G.L.6
Ciampa, A.S.7
Ebbeling, L.G.8
Levy, B.9
Drappatz, J.10
Kesari, S.11
Wen, P.Y.12
-
3
-
-
59949083263
-
Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma
-
10.1200/JCO.2008.16.3055 1:CAS:528:DC%2BD1MXjsVCjs7o%3D 19114704
-
TN Kreisl L Kim K Moore P Duic C Royce I Stroud N Garren M Mackey JA Butman K Camphausen J Park PS Albert HA Fine 2009 Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma J Clin Oncol 27 740 745 10.1200/JCO.2008.16.3055 1:CAS:528:DC%2BD1MXjsVCjs7o%3D 19114704
-
(2009)
J Clin Oncol
, vol.27
, pp. 740-745
-
-
Kreisl, T.N.1
Kim, L.2
Moore, K.3
Duic, P.4
Royce, C.5
Stroud, I.6
Garren, N.7
MacKey, M.8
Butman, J.A.9
Camphausen, K.10
Park, J.11
Albert, P.S.12
Fine, H.A.13
-
4
-
-
70350461699
-
Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma
-
10.1200/JCO.2008.19.8721 1:CAS:528:DC%2BD1MXhtlGgtbbM 19720927
-
HS Friedman MD Prados PY Wen T Mikkelsen D Schiff LE Abrey WK Yung N Paleologos MK Nicholas R Jensen J Vredenburgh J Huang M Zheng T Cloughesy 2009 Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma J Clin Oncol 27 4733 4740 10.1200/JCO.2008.19.8721 1:CAS:528:DC%2BD1MXhtlGgtbbM 19720927
-
(2009)
J Clin Oncol
, vol.27
, pp. 4733-4740
-
-
Friedman, H.S.1
Prados, M.D.2
Wen, P.Y.3
Mikkelsen, T.4
Schiff, D.5
Abrey, L.E.6
Yung, W.K.7
Paleologos, N.8
Nicholas, M.K.9
Jensen, R.10
Vredenburgh, J.11
Huang, J.12
Zheng, M.13
Cloughesy, T.14
-
5
-
-
38349155463
-
Tumor angiogenic and hypoxic profiles predict radiographic response and survival in malignant astrocytoma patients treated with bevacizumab and irinotecan
-
10.1200/JCO.2007.13.3652 1:CAS:528:DC%2BD1cXitVWitbY%3D 18182667
-
S Sathornsumetee Y Cao JE Marcello JE Herndon RE McLendon A Desjardins HS Friedman MW Dewhirst JJ Vredenburgh JN Rich 2008 Tumor angiogenic and hypoxic profiles predict radiographic response and survival in malignant astrocytoma patients treated with bevacizumab and irinotecan J Clin Oncol 26 271 278 10.1200/JCO.2007.13.3652 1:CAS:528:DC%2BD1cXitVWitbY%3D 18182667
-
(2008)
J Clin Oncol
, vol.26
, pp. 271-278
-
-
Sathornsumetee, S.1
Cao, Y.2
Marcello, J.E.3
Herndon, J.E.4
McLendon, R.E.5
Desjardins, A.6
Friedman, H.S.7
Dewhirst, M.W.8
Vredenburgh, J.J.9
Rich, J.N.10
-
6
-
-
11844254414
-
Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy
-
DOI 10.1126/science.1104819
-
RK Jain 2005 Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy Science 307 58 62 10.1126/science.1104819 1:CAS:528:DC%2BD2MXnvFar 15637262 (Pubitemid 40093472)
-
(2005)
Science
, vol.307
, Issue.5706
, pp. 58-62
-
-
Jain, R.K.1
-
7
-
-
33846149645
-
AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients
-
DOI 10.1016/j.ccr.2006.11.021, PII S1535610806003709
-
TT Batchelor AG Sorensen E di Tomaso W Zhang DG Duda KS Cohen KR Kozak DP Cahill P Chen M Zhu M Ancukiewicz MM Mrugala S Plotkin J Drappatz DN Louis P Ivy DT Scadden T Benner JS Loeffler PY Wen RK Jain 2007 AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients Cancer Cell 11 83 95 10.1016/j.ccr.2006.11.021 1:CAS:528:DC%2BD2sXhtFClsLc%3D 17222792 (Pubitemid 46075199)
-
(2007)
Cancer Cell
, vol.11
, Issue.1
, pp. 83-95
-
-
Batchelor, T.T.1
Sorensen, A.G.2
Di Tomaso, E.3
Zhang, W.-T.4
Duda, DanG.5
Cohen, K.S.6
Kozak, K.R.7
Cahill, D.P.8
Chen, P.-J.9
Zhu, M.10
Ancukiewicz, M.11
Mrugala, M.M.12
Plotkin, S.13
Drappatz, J.14
Louis, D.N.15
Ivy, P.16
Scadden, DavidT.17
Benner, T.18
Loeffler, J.S.19
Wen, P.Y.20
Jain, R.K.21
more..
-
8
-
-
0025281789
-
Response criteria for phase II studies of supratentorial malignant glioma
-
1:STN:280:DyaK3c3ptlyitQ%3D%3D 2358840
-
DR Macdonald TL Cascino SCJ Schold JG Cairncross 1990 Response criteria for phase II studies of supratentorial malignant glioma J Clin Oncol 8 1277 1280 1:STN:280:DyaK3c3ptlyitQ%3D%3D 2358840
-
(1990)
J Clin Oncol
, vol.8
, pp. 1277-1280
-
-
MacDonald, D.R.1
Cascino, T.L.2
Schold, S.C.J.3
Cairncross, J.G.4
-
9
-
-
67650147029
-
Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema
-
10.1080/02841850902933123 1:STN:280:DC%2BD1MvjvVahsA%3D%3D 19449234
-
A Server B Kulle J Maehlen R Josefsen T Schellhorn T Kumar CW Langberg PH Nakstad 2009 Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema Acta Radiol 50 682 689 10.1080/02841850902933123 1:STN:280:DC%2BD1MvjvVahsA%3D%3D 19449234
-
(2009)
Acta Radiol
, vol.50
, pp. 682-689
-
-
Server, A.1
Kulle, B.2
Maehlen, J.3
Josefsen, R.4
Schellhorn, T.5
Kumar, T.6
Langberg, C.W.7
Nakstad, P.H.8
-
10
-
-
0029907308
-
High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis
-
DOI 10.1002/mrm.1910360510
-
L Ostergaard RM Weisskoff DA Chesler C Gyldensted BR Rosen 1996 High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: mathematical approach and statistical analysis Magn Reson Med 36 715 725 10.1002/mrm.1910360510 1:STN:280:DyaK2s%2Fntlaktg%3D%3D 8916022 (Pubitemid 26376710)
-
(1996)
Magnetic Resonance in Medicine
, vol.36
, Issue.5
, pp. 715-725
-
-
Ostergaard, L.1
Weisskoff, R.M.2
Chesler, D.A.3
Gyldensted, G.4
Rosen, B.R.5
-
11
-
-
0035139532
-
Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas
-
1:STN:280:DC%2BD3M7nslymsw%3D%3D
-
M Castillo JK Smith L Kwock K Wilber 2001 Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas ANJR Am J Neuroradiol 22 60 64 1:STN:280:DC%2BD3M7nslymsw%3D%3D
-
(2001)
ANJR Am J Neuroradiol
, vol.22
, pp. 60-64
-
-
Castillo, M.1
Smith, J.K.2
Kwock, L.3
Wilber, K.4
-
12
-
-
67650075305
-
Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatment
-
10.1148/radiol.2521081534 19561256
-
WB Pope HJ Kim J Huo J Alger S Brown D Gjertson V Sai JR Young L Tekchandani T Cloughesy PS Mischel A Lai P Nghiemphu S Rahmanuddin J Goldin 2009 Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatment Radiology 252 182 189 10.1148/radiol.2521081534 19561256
-
(2009)
Radiology
, vol.252
, pp. 182-189
-
-
Pope, W.B.1
Kim, H.J.2
Huo, J.3
Alger, J.4
Brown, S.5
Gjertson, D.6
Sai, V.7
Young, J.R.8
Tekchandani, L.9
Cloughesy, T.10
Mischel, P.S.11
Lai, A.12
Nghiemphu, P.13
Rahmanuddin, S.14
Goldin, J.15
-
13
-
-
33750298568
-
Differentiation of recurrent brain tumor versus radiation injury using diffusion tensor imaging in patients with new contrast-enhancing lesions
-
DOI 10.1016/j.mri.2006.07.008, PII S0730725X06002153
-
PC Sundgren X Fan P Weybright RC Welsh RC Carlos M Petrou PE McKeever TL Chenevert 2006 Differentiation of recurrent brain tumor versus radiation injury using diffusion tensor imaging in patients with new contrast-enhancing lesions Magn Reson Imaging 24 1131 1142 10.1016/j.mri.2006.07.008 1:CAS:528: DC%2BD28XhtFers7rO 17071335 (Pubitemid 44635065)
-
(2006)
Magnetic Resonance Imaging
, vol.24
, Issue.9
, pp. 1131-1142
-
-
Sundgren, P.C.1
Fan, X.2
Weybright, P.3
Welsh, R.C.4
Carlos, R.C.5
Petrou, M.6
McKeever, P.E.7
Chenevert, T.L.8
-
14
-
-
56149110299
-
High-grade glioma before and after treatment with radiation and Avastin: Initial observations
-
I Fischer CH Cunliffe RJ Bollo S Raza D Monoky L Chiriboga EC Parker JG Golfinos PJ Kelly EA Knopp ML Gruber D Zagzag A Narayana 2008 High-grade glioma before and after treatment with radiation and Avastin: initial observations Neurooncology 10 700 708
-
(2008)
Neurooncology
, vol.10
, pp. 700-708
-
-
Fischer, I.1
Cunliffe, C.H.2
Bollo, R.J.3
Raza, S.4
Monoky, D.5
Chiriboga, L.6
Parker, E.C.7
Golfinos, J.G.8
Kelly, P.J.9
Knopp, E.A.10
Gruber, M.L.11
Zagzag, D.12
Narayana, A.13
-
15
-
-
66349121063
-
Edema control by cediranib, a vascular endothelial growth factor receptor-targeted kinase inhibitor, prolongs survival despite persistent brain tumor growth in mice
-
10.1200/JCO.2008.19.9356 1:CAS:528:DC%2BD1MXmvVOhsbY%3D 19332720
-
WS Kamoun CD Ley CT Farrar AM Duyverman J Lahdenranta DA Lacorre TT Batchelor E di Tomaso DG Duda LL Munn D Fukumura AG Sorensen RK Jain 2009 Edema control by cediranib, a vascular endothelial growth factor receptor-targeted kinase inhibitor, prolongs survival despite persistent brain tumor growth in mice J Clin Oncol 27 2542 2552 10.1200/JCO.2008.19.9356 1:CAS:528: DC%2BD1MXmvVOhsbY%3D 19332720
-
(2009)
J Clin Oncol
, vol.27
, pp. 2542-2552
-
-
Kamoun, W.S.1
Ley, C.D.2
Farrar, C.T.3
Duyverman, A.M.4
Lahdenranta, J.5
Lacorre, D.A.6
Batchelor, T.T.7
Di Tomaso, E.8
Duda, D.G.9
Munn, L.L.10
Fukumura, D.11
Sorensen, A.G.12
Jain, R.K.13
-
16
-
-
1442290142
-
Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms
-
1:CAS:528:DC%2BD2cXht1Gjtrg%3D 14657001
-
R Erber A Thurnher AD Katsen G Groth H Kerger H Hammes MD Menger A Ullrich P Vajkoczy 2004 Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms FASEB J 18 338 340 1:CAS:528:DC%2BD2cXht1Gjtrg%3D 14657001
-
(2004)
FASEB J
, vol.18
, pp. 338-340
-
-
Erber, R.1
Thurnher, A.2
Katsen, A.D.3
Groth, G.4
Kerger, H.5
Hammes, H.6
Menger, M.D.7
Ullrich, A.8
Vajkoczy, P.9
-
17
-
-
67649411967
-
Antagonism of the mammalian target of rapamycin selectively mediates metabolic effects of epidermal growth factor receptor inhibition and protects human malignant glioma cells from hypoxia-induced cell death
-
10.1093/brain/awp093 19416948
-
MW Ronellenfitsch DP Brucker MC Burger S Wolking F Tritschler J Rieger W Wick M Weller JP Steinbach 2009 Antagonism of the mammalian target of rapamycin selectively mediates metabolic effects of epidermal growth factor receptor inhibition and protects human malignant glioma cells from hypoxia-induced cell death Brain 132 1509 1522 10.1093/brain/awp093 19416948
-
(2009)
Brain
, vol.132
, pp. 1509-1522
-
-
Ronellenfitsch, M.W.1
Brucker, D.P.2
Burger, M.C.3
Wolking, S.4
Tritschler, F.5
Rieger, J.6
Wick, W.7
Weller, M.8
Steinbach, J.P.9
-
18
-
-
0037478437
-
Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene
-
DOI 10.1016/S1535-6108(03)00085-0, PII S1535610803000850
-
S Pennacchietti P Michieli M Galluzzo M Mazzone S Giordano PM Comoglio 2003 Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene Cancer Cell 3 347 361 10.1016/S1535-6108(03)00085-0 12726861 (Pubitemid 38340304)
-
(2003)
Cancer Cell
, vol.3
, Issue.4
, pp. 347-361
-
-
Pennacchietti, S.1
Michieli, P.2
Galluzzo, M.3
Mazzone, M.4
Giordano, S.5
Comoglio, P.M.6
-
19
-
-
34147169062
-
Inhibition of ADAM17 reduces hypoxia-induced brain tumor cell invasiveness
-
DOI 10.1111/j.1349-7006.2007.00440.x
-
X Zheng F Jiang M Katakowski SN Kalkanis X Hong X Zhang ZG Zhang H Yang M Chopp 2007 Inhibition of ADAM17 reduces hypoxia-induced brain tumor cell invasiveness Cancer Sci 98 674 684 10.1111/j.1349-7006.2007.00440.x 1:CAS:528:DC%2BD2sXkvFSkur4%3D 17355261 (Pubitemid 46563443)
-
(2007)
Cancer Science
, vol.98
, Issue.5
, pp. 674-684
-
-
Zheng, X.1
Jiang, F.2
Katakowski, M.3
Kalkanis, S.N.4
Hong, X.5
Zhang, X.6
Zhang, Z.G.7
Yang, H.8
Chopp, M.9
-
20
-
-
60649106195
-
Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis
-
10.1016/j.ccr.2009.01.027 19249680
-
M Pàez-Ribes E Allen J Hudock T Takeda H Okuyama F Viñals M Inoue G Bergers D Hanahan O Casanovas 2009 Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis Cancer Cell 15 220 231 10.1016/j.ccr.2009.01.027 19249680
-
(2009)
Cancer Cell
, vol.15
, pp. 220-231
-
-
Pàez-Ribes, M.1
Allen, E.2
Hudock, J.3
Takeda, T.4
Okuyama, H.5
Viñals, F.6
Inoue, M.7
Bergers, G.8
Hanahan, D.9
Casanovas, O.10
-
21
-
-
0034306974
-
Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions
-
1:CAS:528:DC%2BD3cXns1ehtL4%3D 11034104
-
CG Lee M Heijn E di Tomaso G Griffon-Etienne M Ancukiewicz C Koike KR Park N Ferrara RK Jain HD Suit Y Boucher 2000 Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions Cancer Res 60 5565 5570 1:CAS:528:DC%2BD3cXns1ehtL4%3D 11034104
-
(2000)
Cancer Res
, vol.60
, pp. 5565-5570
-
-
Lee, C.G.1
Heijn, M.2
Di Tomaso, E.3
Griffon-Etienne, G.4
Ancukiewicz, M.5
Koike, C.6
Park, K.R.7
Ferrara, N.8
Jain, R.K.9
Suit, H.D.10
Boucher, Y.11
-
22
-
-
19944422751
-
Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: Role of oxygenation, angiopoietin-1, and matrix metalloproteinases
-
1:CAS:528:DC%2BD2MXktVantw%3D%3D 15607960
-
F Winkler SV Kozin RT Tong SS Chae MF Booth I Garkavtsev L Xu DJ Hicklin D Fukumura E di Tomaso JJ Munn RK Jain 2004 Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases Cancer Cell 6 553 563 1:CAS:528:DC%2BD2MXktVantw%3D%3D 15607960
-
(2004)
Cancer Cell
, vol.6
, pp. 553-563
-
-
Winkler, F.1
Kozin, S.V.2
Tong, R.T.3
Chae, S.S.4
Booth, M.F.5
Garkavtsev, I.6
Xu, L.7
Hicklin, D.J.8
Fukumura, D.9
Di Tomaso, E.10
Munn, J.J.11
Jain, R.K.12
-
23
-
-
34548213721
-
Efficacy and tolerability of temozolomide in an alternating weekly regimen in patients with recurrent glioma
-
DOI 10.1200/JCO.2007.10.7722
-
A Wick J Felsberg JP Steinbach U Herrlinger M Platten B Blaschke R Meyermann G Reifenberger M Weller W Wick 2007 Efficacy and tolerability of temozolomide in an alternating weekly regimen in patients with recurrent glioma J Clin Oncol 25 3357 3361 10.1200/JCO.2007.10.7722 1:CAS:528:DC%2BD2sXhtVWqs7nO 17664483 (Pubitemid 47325623)
-
(2007)
Journal of Clinical Oncology
, vol.25
, Issue.22
, pp. 3357-3361
-
-
Wick, A.1
Felsberg, J.2
Steinbach, J.P.3
Herrlinger, U.4
Platten, M.5
Blaschke, B.6
Meyermann, R.7
Reifenberger, G.8
Weller, M.9
Wick, W.10
|